Answers are grounded in this paper and cite their sources.
To the Editor: HIV isolation and polymerase chain reaction(PCR) DNA-based techniques for laboratory diagnosis of pediatric AIDS are expensive and difficult to perform in undeveloped countries(1). Enzyme immunoassays (EIA) to detect serum HIV-1 IgA and p24 antigen have been suggested as a diagnostic alternative in such settings(2-4). The specificity of these tests is excellent, but sensitivity is usually diminished in patients younger than 6 months of age. Recently, Lyamuya et al. reported improved diagnostic sensitivity using a heatdenatured p24 antigen (HD p24) enzyme-linked immunosorbent assay (ELISA) with signal amplification(5). To assess the usefulness of these approaches in the routine diagnosis of pediatric AIDS in resource-poor settings, we studied 53 consecutive infants suspected of having AIDS born to anti-HIV IgG-positive mothers and categorized according to the provisional pediatric World Health Organization's clinical case definition for AIDS(6). Children were referred to our laboratory from the Maputo Central Hospital, Mozambique. They were tested using commercial ELISA kits (Sanofi Pasteur, Marnes-la-Coquette, France): Genelavia, for anti-HIV-1 IgA, substituting the kit conjugate with an anti-human IgA peroxidase and depleting the testing serum of IgG by the rProtein G affinity method (Quik-Sep IgM, Isolab, Akron, OH, U.S.A.)(7); and Elavia Ag I, for p24 antigen, after heatdenaturation of sera(8). The ELISA results were repeatedly nonreactive with sera from pediatric patients with suspected HIV infection (N = 87) born to anti-HIV IgG-negative mothers. Pools of these sera were subsequently used as negative controls. Assuming that patients with a positive anti-HIV-1 IgA or HD p24 ELISA test result are truly infected, clinical suspicion of pediatric AIDS shows a 84.5% specificity in this series (45 of 53 patients). Specific IgA was more frequently detected than HD p24 (88.8% versus 73.3%, respectively) (Table 1). HD p24 testing would and only five additional HIV cases to anti-HIV-1 IgA results, three of them in the 4- to 6-month age group. Distribution of mean absorbance to cut-off (A/CO) ratios according to age (Fig. 1) showed a clear advantage of IgA-specific testing over HD p24 ELISA testing, emphasizing the need for signal amplification in the latter assay(9). Additionally, the reagent price per test of the modified IgA anti-HIV-1 ELISA (including IgG serum depletion and conjugate plus substrate substitutions) was 51% lower than that of the p24 assay.TABLE 1: Distribution of enzyme-linked immunosorbert assay(ELISA) seropositivity according to ageFIG. 1: Distribution of mean absorbance to cut-off ratios according to age.However, in the 4- to 6-month age group, HIV-1-specific IgA was less frequently detected (Table 1) and gave the lowest signal-to-noise ratio (Fig. 1). Similar findings in infants younger than 6 or 3 months of age have been reported in other studies(2,10,11). In conclusion, this study suggests that anti-HIV-1 IgA serologic testing may be a useful technique for routine laboratory diagnosis of pediatric AIDS in resource-poor countries. Compared with HD p24 detection, it is more sensitive, provides a better signal-to-noise ratio, does not seem to be negatively affected by increasing age of the patient, and is cheaper. A simple, rapid anti-HIV IgA assay not requiring IgG serum depletion would be useful in such settings. Acknowledgment: We thank Dr. Julie L. Cliff for her review of the manuscript. Irene Koulinska Sérgio Stakteas Paula Vaz Jorge Barreto Instituto Nacional de Saude; Hospital Central de Maputo; Maputo, Mozambique
No takes yet. Share an insight, caveat, or question.
Koulinska et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: